Antibody Drug Conjugate (ADC) Research Services
Antibody Drug Conjugate (ADC) Research Services
ADCs combine the specificity of antibodies with the potency of targeted payloads, making them one of the fastest-growing therapeutic modalities in oncology.
Our Antibody Drug Conjugate (ADC) Research Services support every stage of ADC evaluation, including:
- Target binding characterization
- Internalization studies
- Payload activity assessment
- Tumor cell killing assays
- Bystander effect analysis
- Functional immune response evaluation
- Comparative candidate assessment
Our goal is to help sponsors understand how ADCs perform in biologically relevant systems before advancing into clinical development.
